<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39554470</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1178-6973</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Infection and drug resistance</Title><ISOAbbreviation>Infect Drug Resist</ISOAbbreviation></Journal><ArticleTitle>Risk Factors for Secondary Organizing Pneumonia and Acute Fibrinous and Organizing Pneumonia in Patients with COVID-19 Pneumonia.</ArticleTitle><Pagination><StartPage>5017</StartPage><EndPage>5026</EndPage><MedlinePgn>5017-5026</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/IDR.S481540</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">Secondary organizing pneumonia (OP) and acute fibrinous and organizing pneumonia (AFOP) are frequently observed in cases of COVID-19 pneumonia. Nevertheless, the identification of risk factors related to OP/AFOP and their impact on patient outcomes remain inadequately elucidated.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="UNASSIGNED">This retrospective study aimed to identify risk factors associated with OP/AFOP in patients with COVID-19 pneumonia and to compare clinical outcomes between patients with and without OP/AFOP. The study included hospitalized patients with COVID-19 pneumonia admitted between July 1 and September 30, 2021. Factors associated with OP/AFOP were identified using multivariable regression analysis. Additionally, a multivariable Cox proportional hazard model was used to evaluate the association of OP/AFOP with 90-day mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Among the 666 hospitalized patients with COVID-19 pneumonia, 53 (8%) developed OP/AFOP during their admission. When compared to patients younger than 50 years old, those aged 50-70 and over 70 years old exhibited an increased risk of developing OP/AFOP, with adjusted odds ratios (aOR) of 3.87 (95% CI, 1.24-12.11; P=0.02) and 5.74 (95% CI, 1.80-18.27; P=0.003), respectively. Other factors associated with OP/AFOP included a history of diabetes mellitus (aOR 2.37; 95% CI, 1.27-4.44; P=0.01) and patients with oxygen saturation at admission below 88% (aOR 4.52; 95% CI, 1.22-16.67; P=0.02). Furthermore, the presence of OP/AFOP was correlated with an increased risk of various complications, such as respiratory failure, acute kidney injury, secondary infections, pneumothorax, pneumomediastinum, and pulmonary embolism. Lastly, patients with OP/AFOP exhibited significantly higher 90-day mortality (adjusted hazard ratio 3.40; 95% CI, 1.68-6.92; P=0.001) compared to those without OP/AFOP.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">We identified factors associated with an increased risk of OP/AFOP in patients with COVID-19 pneumonia, which included age ≥50 years, a history of DM, and hypoxemia on admission (SpO2 &lt;88%). Furthermore, our study revealed that OP/AFOP was significantly linked to higher 90-day mortality.</AbstractText><CopyrightInformation>© 2024 Aikwanich et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aikwanich</LastName><ForeName>Alisa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, 10400, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eksombatchai</LastName><ForeName>Dararat</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, 10400, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petnak</LastName><ForeName>Tananchai</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, 10400, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tassaneeyasin</LastName><ForeName>Tanapat</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samut Prakan, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boonsarngsuk</LastName><ForeName>Viboon</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, 10400, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Infect Drug Resist</MedlineTA><NlmUniqueID>101550216</NlmUniqueID><ISSNLinking>1178-6973</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">acute fibrinous and organizing pneumonia</Keyword><Keyword MajorTopicYN="N">complication</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">organizing pneumonia</Keyword><Keyword MajorTopicYN="N">pneumonia</Keyword><Keyword MajorTopicYN="N">risk factor</Keyword></KeywordList><CoiStatement>The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>16</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>16</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39554470</ArticleId><ArticleId IdType="pmc">PMC11566205</ArticleId><ArticleId IdType="doi">10.2147/IDR.S481540</ArticleId><ArticleId IdType="pii">481540</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gebru AA, Birhanu T, Wendimu E, et al. Global burden of COVID-19: situational analysis and review. Hum Antibodies. 2021;29(2):139–148. doi:10.3233/HAB-200420</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/HAB-200420</ArticleId><ArticleId IdType="pubmed">32804122</ArticleId></ArticleIdList></Reference><Reference><Citation>Chae KJ, Chung MJ, Jin GY, et al. Radiologic-pathologic correlation of interstitial lung abnormalities and predictors for progression and survival. Eur Radiol. 2022;32(4):2713–2723. doi:10.1007/s00330-021-08378-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-021-08378-8</ArticleId><ArticleId IdType="pubmed">34984519</ArticleId></ArticleIdList></Reference><Reference><Citation>Kory P, Kanne JP. SARS-CoV-2 organising pneumonia: ‘Has there been a widespread of failure to identify and treat this prevalent condition in COVID-19?’ BMJ Open Respir Res. 2020;7:e000724. doi:10.1136/bmjresp-2020-000724</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2020-000724</ArticleId><ArticleId IdType="pmc">PMC7509945</ArticleId><ArticleId IdType="pubmed">32963028</ArticleId></ArticleIdList></Reference><Reference><Citation>Beasley MB, Franks TJ, Galvin JR, Gochuico B, Travis WD. Acute fibrinous and organizing pneumonia: a histologic pattern of lung injury and possible variant of diffuse alveolar damage. Arch Pathol Lab Med. 2002;126(9):1064–1070. doi:10.5858/2002-126-1064-AFAOP</Citation><ArticleIdList><ArticleId IdType="doi">10.5858/2002-126-1064-AFAOP</ArticleId><ArticleId IdType="pubmed">12204055</ArticleId></ArticleIdList></Reference><Reference><Citation>Copin M-C, Parmentier E, Daburcq T, Poissy J, Mathieu D; The Lille COVID-19 and Anatomopathology Group. Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection. Intensive Care Med. 2020;46:1124–1126. doi:10.1007/s00134-020-06057-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06057-8</ArticleId><ArticleId IdType="pmc">PMC7178098</ArticleId><ArticleId IdType="pubmed">32328726</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian S, Xiong Y, Liu H, et al. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod Pathol. 2020;33(6):1007–1014. doi:10.1038/s41379-020-0536-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41379-020-0536-x</ArticleId><ArticleId IdType="pmc">PMC7156231</ArticleId><ArticleId IdType="pubmed">32291399</ArticleId></ArticleIdList></Reference><Reference><Citation>Buja LM, Wolf DA, Zhao B, et al. The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities. Cardiovasc Pathol. 2020;48:107233. doi:10.1016/j.carpath.2020.107233</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carpath.2020.107233</ArticleId><ArticleId IdType="pmc">PMC7204762</ArticleId><ArticleId IdType="pubmed">32434133</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin C, Tian C, Wang Y, et al. A pattern categorization of CT findings to predict outcome of COVID-19 pneumonia. Front Public Health. 2020;8:567672. doi:10.3389/fpubh.2020.567672</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.567672</ArticleId><ArticleId IdType="pmc">PMC7531052</ArticleId><ArticleId IdType="pubmed">33072703</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Jin C, Wu CC, et al. Organizing pneumonia of COVID-19: time dependent evolution and outcome in CT findings. PLoS One. 2020;15(11):e0240347. doi:10.1371/journal.pone.0240347</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240347</ArticleId><ArticleId IdType="pmc">PMC7657520</ArticleId><ArticleId IdType="pubmed">33175876</ArticleId></ArticleIdList></Reference><Reference><Citation>Onishi Y, Kawamura T, Higashino T, Mimura R, Tsukamoto H, Sasaki S. Clinical features of acute fibrinous and organizing pneumonia: an early histologic pattern of various acute inflammatory lung diseases. PLoS One. 2021;16(4):e0249300. doi:10.1371/journal.pone.0249300</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0249300</ArticleId><ArticleId IdType="pmc">PMC8016294</ArticleId><ArticleId IdType="pubmed">33793625</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannaga AS, Tabuso M, Farrugia A, et al. C-reactive protein and albumin association with mortality of hospitalised SARS-CoV-2 patients: a tertiary hospital experience. Clin Med. 2020;20(5):463–467. doi:10.7861/clinmed.2020-0424</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0424</ArticleId><ArticleId IdType="pmc">PMC7539728</ArticleId><ArticleId IdType="pubmed">32934038</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934–943. doi:10.1001/jamainternmed.2020.0994</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.0994</ArticleId><ArticleId IdType="pmc">PMC7070509</ArticleId><ArticleId IdType="pubmed">32167524</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20(4):425–434. doi:10.1016/S1473-3099(20)30086-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30086-4</ArticleId><ArticleId IdType="pmc">PMC7159053</ArticleId><ArticleId IdType="pubmed">32105637</ArticleId></ArticleIdList></Reference><Reference><Citation>Bialek S, Boundy E, Bowen V. Severe outcomes among patients with Coronavirus disease 2019 (COVID-19) - United States, February 12-March 16, 2020. Morb Mortal Wkly Rep. 2020;69(12):343–346. doi:10.15585/mmwr.mm6912e2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6912e2</ArticleId><ArticleId IdType="pmc">PMC7725513</ArticleId><ArticleId IdType="pubmed">32214079</ArticleId></ArticleIdList></Reference><Reference><Citation>Pence BD. Severe COVID-19 and aging: are monocytes the key? Geroscience. 2020;42(4):1051–1061. doi:10.1007/s11357-020-00213-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-020-00213-0</ArticleId><ArticleId IdType="pmc">PMC7299454</ArticleId><ArticleId IdType="pubmed">32556942</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z, Peng F, Xu B, et al. Risk factors of critical &amp; mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020;81(2):e16–e25. doi:10.1016/j.jinf.2020.04.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.04.021</ArticleId><ArticleId IdType="pmc">PMC7177098</ArticleId><ArticleId IdType="pubmed">32335169</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W, Sun NN, Gao HN, et al. Risk factors analysis of COVID-19 patients with ARDS and prediction based on machine learning. Sci Rep. 2021;11(1):2933. doi:10.1038/s41598-021-82492-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-82492-x</ArticleId><ArticleId IdType="pmc">PMC7858607</ArticleId><ArticleId IdType="pubmed">33536460</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 2020;14(2):185–192. doi:10.1007/s11684-020-0754-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11684-020-0754-0</ArticleId><ArticleId IdType="pmc">PMC7088738</ArticleId><ArticleId IdType="pubmed">32170560</ArticleId></ArticleIdList></Reference><Reference><Citation>Okoduwa SI, Mhya DH, Enang IA, Salawu AO. Diabetes mellitus and COVID-19: possible interactions and mechanisms in comorbid patients. J Health Sci Med Res. 2023;41(2):2022904.</Citation></Reference><Reference><Citation>Chong WH, Saha BK, Chopra A. Does COVID-19 pneumonia signify secondary organizing pneumonia?: a narrative review comparing the similarities between these two distinct entities. Heart Lung. 2021;50(5):667–674. doi:10.1016/j.hrtlng.2021.04.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrtlng.2021.04.009</ArticleId><ArticleId IdType="pmc">PMC8164344</ArticleId><ArticleId IdType="pubmed">34098237</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Subramanian A, Wang TT. An aberrant inflammatory response in severe COVID-19. Cell Host Microbe. 2021;29(7):1043–1047. doi:10.1016/j.chom.2021.06.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2021.06.018</ArticleId><ArticleId IdType="pmc">PMC8279571</ArticleId><ArticleId IdType="pubmed">34265243</ArticleId></ArticleIdList></Reference><Reference><Citation>Raoufi M, Kahkooei S, Haseli S, Robatjazi F, Bahri J, Khalili N. Organizing pneumonia-like pattern in COVID-19. Adv Respir Med. 2021;565–569. doi:10.5603/ARM.a2021.0081</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/ARM.a2021.0081</ArticleId><ArticleId IdType="pubmed">34612508</ArticleId></ArticleIdList></Reference><Reference><Citation>Parra Gordo ML, Buitrago Weiland G, Grau García M, Arenaza Choperena G. Radiologic aspects of COVID-19 pneumonia: outcomes and thoracic complications. Radiología. 2021;63(1):74–88. doi:10.1016/j.rx.2020.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rx.2020.11.002</ArticleId><ArticleId IdType="pmc">PMC7687358</ArticleId><ArticleId IdType="pubmed">33334590</ArticleId></ArticleIdList></Reference><Reference><Citation>Takumida H, Izumi S, Sakamoto K, et al. Sustained coronavirus disease 2019-related organizing pneumonia successfully treated with corticosteroid. Respir Investig. 2021;59(3):377–381. doi:10.1016/j.resinv.2020.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resinv.2020.12.005</ArticleId><ArticleId IdType="pmc">PMC7825973</ArticleId><ArticleId IdType="pubmed">33547007</ArticleId></ArticleIdList></Reference><Reference><Citation>Vadász I, Husain-Syed F, Dorfmüller P, et al. Severe organising pneumonia following COVID-19. Thorax. 2021;76(2):201–204. doi:10.1136/thoraxjnl-2020-216088</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216088</ArticleId><ArticleId IdType="pubmed">33177230</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein NC, Go CH, Cunha BA. Infections associated with steroid use. Infect Dis Clin North Am. 2001;15(2):423–432,viii. doi:10.1016/S0891-5520(05)70154-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5520(05)70154-9</ArticleId><ArticleId IdType="pubmed">11447704</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhary NS, Donnelly JP, Moore JX, Baddley JW, Safford MM, Wang HE. Association of baseline steroid use with long-term rates of infection and sepsis in the REGARDS cohort. Critical Care. 2017;21(1):185. doi:10.1186/s13054-017-1767-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-017-1767-1</ArticleId><ArticleId IdType="pmc">PMC5508766</ArticleId><ArticleId IdType="pubmed">28701217</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanmarcke C, Steelandt T, Vliegen AS. Air-leak syndrome with spontaneous tension pneumothorax and pneumomediastinum caused by bleomycin-induced organizing pneumonia. J Belgian Soc Radiol. 2022;106(1):138. doi:10.5334/jbsr.2880</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/jbsr.2880</ArticleId><ArticleId IdType="pmc">PMC9801663</ArticleId><ArticleId IdType="pubmed">36618028</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W-J, Ni Z-Y, Hu Y, et al. Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi:10.1056/NEJMoa2002032</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–847. doi:10.1111/jth.14768</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14768</ArticleId><ArticleId IdType="pmc">PMC7166509</ArticleId><ArticleId IdType="pubmed">32073213</ArticleId></ArticleIdList></Reference><Reference><Citation>Torrealba JR, Fisher S, Kanne JP, et al. Pathology-radiology correlation of common and uncommon computed tomographic patterns of organizing pneumonia. Hum Pathol. 2017;71:30–40. doi:10.1016/j.humpath.2017.10.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humpath.2017.10.028</ArticleId><ArticleId IdType="pubmed">29122655</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YS, Kang UR, Kim YH. The spectrum of CT findings of COVID-19 pneumonia: acute alveolar insult and organizing pneumonia as different phases of lung injury and repair. Taehan Yongsang Uihakhoe Chi. 2021;82(2):359–370. doi:10.3348/jksr.2020.0142</Citation><ArticleIdList><ArticleId IdType="doi">10.3348/jksr.2020.0142</ArticleId><ArticleId IdType="pmc">PMC9431937</ArticleId><ArticleId IdType="pubmed">36238728</ArticleId></ArticleIdList></Reference><Reference><Citation>Andre M, Lau L-S, Pokharel MD, et al. From alpha to omicron: how different variants of concern of the SARS-Coronavirus-2 impacted the world. Biology. 2023;12(9):1267. doi:10.3390/biology12091267</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology12091267</ArticleId><ArticleId IdType="pmc">PMC10525159</ArticleId><ArticleId IdType="pubmed">37759666</ArticleId></ArticleIdList></Reference><Reference><Citation>Iuliano AD. Trends in disease severity and health care utilization during the early Omicron variant period compared with previous SARS-CoV-2 high transmission periods—United States, December 2020–January 2022. Morb Mortal Wkly Rep. 2022;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9351529</ArticleId><ArticleId IdType="pubmed">35085225</ArticleId></ArticleIdList></Reference><Reference><Citation>Khandia R, Singhal S, Alqahtani T, et al. Emergence of SARS-CoV-2 Omicron (B. 1.1. 529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic. Environ Res. 2022;209:112816. doi:10.1016/j.envres.2022.112816</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envres.2022.112816</ArticleId><ArticleId IdType="pmc">PMC8798788</ArticleId><ArticleId IdType="pubmed">35093310</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>